View in EDS

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Saved in:
Bibliographic Details
Title: Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Authors: Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Urisman A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Pathology, University of California, San Francisco, San Francisco, CA., Gubens MA; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Mulvey CK; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Allen GM; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Shiboski SC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA., Chakrabarti T; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Aredo JV; Department of Medicine, University of California, San Francisco, San Francisco, CA., Bacaltos B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Gee M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Tan L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Jones KD; Department of Pathology, University of California, San Francisco, San Francisco, CA., Devine WP; Department of Pathology, University of California, San Francisco, San Francisco, CA.; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA., Doebele RC; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Aisner DL; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO., Patil T; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Schenk EL; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Bivona TG; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub, San Francisco, CA., Riess JW; Department of Medicine, University of California Davis, Sacramento, CA., Coleman M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Kratz JR; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA., Jablons DM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3105-3114. Date of Electronic Publication: 2024 Jul 19.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39028931
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Blakely+CM%22">Blakely CM</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Urisman+A%22">Urisman A</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Pathology, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Gubens+MA%22">Gubens MA</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Mulvey+CK%22">Mulvey CK</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Allen+GM%22">Allen GM</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Shiboski+SC%22">Shiboski SC</searchLink>; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Rotow+JK%22">Rotow JK</searchLink>; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chakrabarti+T%22">Chakrabarti T</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Kerr+DL%22">Kerr DL</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Aredo+JV%22">Aredo JV</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Bacaltos+B%22">Bacaltos B</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Gee+M%22">Gee M</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Tan+L%22">Tan L</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Jones+KD%22">Jones KD</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Devine+WP%22">Devine WP</searchLink>; Department of Pathology, University of California, San Francisco, San Francisco, CA.; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Doebele+RC%22">Doebele RC</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Aisner+DL%22">Aisner DL</searchLink>; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Patil+T%22">Patil T</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Schenk+EL%22">Schenk EL</searchLink>; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Bivona+TG%22">Bivona TG</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Chan Zuckerberg Biohub, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Riess+JW%22">Riess JW</searchLink>; Department of Medicine, University of California Davis, Sacramento, CA.<br /><searchLink fieldCode="AU" term="%22Coleman+M%22">Coleman M</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Kratz+JR%22">Kratz JR</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Jablons+DM%22">Jablons DM</searchLink>; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.; Department of Surgery, University of California, San Francisco, San Francisco, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3105-3114. <i>Date of Electronic Publication: </i>2024 Jul 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39028931
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.24.00071
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3105
    Titles:
      – TitleFull: Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blakely CM
      – PersonEntity:
          Name:
            NameFull: Urisman A
      – PersonEntity:
          Name:
            NameFull: Gubens MA
      – PersonEntity:
          Name:
            NameFull: Mulvey CK
      – PersonEntity:
          Name:
            NameFull: Allen GM
      – PersonEntity:
          Name:
            NameFull: Shiboski SC
      – PersonEntity:
          Name:
            NameFull: Rotow JK
      – PersonEntity:
          Name:
            NameFull: Chakrabarti T
      – PersonEntity:
          Name:
            NameFull: Kerr DL
      – PersonEntity:
          Name:
            NameFull: Aredo JV
      – PersonEntity:
          Name:
            NameFull: Bacaltos B
      – PersonEntity:
          Name:
            NameFull: Gee M
      – PersonEntity:
          Name:
            NameFull: Tan L
      – PersonEntity:
          Name:
            NameFull: Jones KD
      – PersonEntity:
          Name:
            NameFull: Devine WP
      – PersonEntity:
          Name:
            NameFull: Doebele RC
      – PersonEntity:
          Name:
            NameFull: Aisner DL
      – PersonEntity:
          Name:
            NameFull: Patil T
      – PersonEntity:
          Name:
            NameFull: Schenk EL
      – PersonEntity:
          Name:
            NameFull: Bivona TG
      – PersonEntity:
          Name:
            NameFull: Riess JW
      – PersonEntity:
          Name:
            NameFull: Coleman M
      – PersonEntity:
          Name:
            NameFull: Kratz JR
      – PersonEntity:
          Name:
            NameFull: Jablons DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 09
              Text: 2024 Sep 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 26
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1